2004
DOI: 10.1016/j.jhin.2003.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
71
0
2

Year Published

2004
2004
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 115 publications
(77 citation statements)
references
References 31 publications
4
71
0
2
Order By: Relevance
“…Culturing of wounds or skin lesions in addition to the anterior nares increases the likelihood of detecting MRSA colonization (31,38). Although the anterior nares are understandably considered the best single body site from which to take specimens for culture to screen patients for unrecognized MRSA colonization, rectal or gastrointestinal carriage occurs in a substantial proportion of patients with MRSA nasal colonization (4,5,10,29,40). We decided to conduct MRSA surveillance by screening stool specimens submitted to the laboratory for C. difficile toxin A/B assays for several reasons.…”
Section: Discussionmentioning
confidence: 99%
“…Culturing of wounds or skin lesions in addition to the anterior nares increases the likelihood of detecting MRSA colonization (31,38). Although the anterior nares are understandably considered the best single body site from which to take specimens for culture to screen patients for unrecognized MRSA colonization, rectal or gastrointestinal carriage occurs in a substantial proportion of patients with MRSA nasal colonization (4,5,10,29,40). We decided to conduct MRSA surveillance by screening stool specimens submitted to the laboratory for C. difficile toxin A/B assays for several reasons.…”
Section: Discussionmentioning
confidence: 99%
“…More novel treatment modalities for intestinal MRSA elimination to control transmission or subsequent infections, e.g., using oral vancomycin, have been described merely in uncontrolled or observational studies. Oral vancomycin treatment results were reported that showed that the eradication of MRSA intestinal carriage by enteral vancomycin in subsets of adult ICU patients [58][59][60] as well as in pediatric patients [61,62] was effective, but had limited effect on the prevention of transmission. The results from prospective controlled studies of intestinal MRSA decolonization are urgently awaited.…”
Section: Eradication Of Intestinal Carriagementioning
confidence: 99%
“…Two recent randomized controlled trials demonstrated that SDD does not increase resistance but actually reduces antibiotic resistance [4,5]. Moreover five long-term SDD observational studies monitored antimicrobial resistance between 2 and 7 years, and reported that bacterial resistance associated with SDD was not a clinical problem [7][8][9][10][11]. These studies have some potential weaknesses: one study was a retrospective case-control study, two studies assessed the percentage of antibiotic-resistant isolates instead of the incidence of patients who acquired antibiotic-resistant bacteria (ARB) [9,10], two studies specifically estimate the efficacy and safety of enteral vancomycin to eradicate oxacillin-resistant Staphylococcus aureus (ORSA) [7,8].…”
Section: Introductionmentioning
confidence: 99%